JP2010534646A5 - - Google Patents

Download PDF

Info

Publication number
JP2010534646A5
JP2010534646A5 JP2010517535A JP2010517535A JP2010534646A5 JP 2010534646 A5 JP2010534646 A5 JP 2010534646A5 JP 2010517535 A JP2010517535 A JP 2010517535A JP 2010517535 A JP2010517535 A JP 2010517535A JP 2010534646 A5 JP2010534646 A5 JP 2010534646A5
Authority
JP
Japan
Prior art keywords
aza
bicyclo
hex
methyl
ylmethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010517535A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010534646A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2008/052985 external-priority patent/WO2009016560A2/en
Publication of JP2010534646A publication Critical patent/JP2010534646A/ja
Publication of JP2010534646A5 publication Critical patent/JP2010534646A5/ja
Pending legal-status Critical Current

Links

JP2010517535A 2007-07-27 2008-07-25 トランス−3−アザ−ビシクロ[3.1.0]ヘキサン誘導体 Pending JP2010534646A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IB2007052987 2007-07-27
IB2008051167 2008-03-28
PCT/IB2008/052985 WO2009016560A2 (en) 2007-07-27 2008-07-25 Trans-3-aza-bicyclo[3.1.0]hexane derivatives

Publications (2)

Publication Number Publication Date
JP2010534646A JP2010534646A (ja) 2010-11-11
JP2010534646A5 true JP2010534646A5 (en:Method) 2011-09-01

Family

ID=40130778

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010517535A Pending JP2010534646A (ja) 2007-07-27 2008-07-25 トランス−3−アザ−ビシクロ[3.1.0]ヘキサン誘導体

Country Status (8)

Country Link
EP (1) EP2185512B1 (en:Method)
JP (1) JP2010534646A (en:Method)
CN (1) CN101790515A (en:Method)
AT (1) ATE493386T1 (en:Method)
CA (1) CA2693817A1 (en:Method)
DE (1) DE602008004265D1 (en:Method)
TW (1) TW200904799A (en:Method)
WO (1) WO2009016560A2 (en:Method)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008038251A2 (en) * 2006-09-29 2008-04-03 Actelion Pharmaceuticals Ltd 3-aza-bicyclo[3.1.0]hexane derivatives
WO2008150364A1 (en) 2007-05-23 2008-12-11 Merck & Co., Inc. Cyclopropyl pyrrolidine orexin receptor antagonists
EP2275421A1 (en) 2009-07-15 2011-01-19 Rottapharm S.p.A. Spiro amino compounds suitable for the treatment of inter alia sleep disorders and drug addiction
WO2011051342A1 (en) 2009-10-30 2011-05-05 Janssen Pharmaceutica Nv IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AND THEIR USE AS PDE10 INHIBITORS
WO2011082268A2 (en) 2009-12-30 2011-07-07 Arqule Inc. Substituted naphthalenyl-pyrimidine compounds
AR080754A1 (es) 2010-03-09 2012-05-09 Janssen Pharmaceutica Nv Derivados de imidazo (1,2-a) pirazina y su uso como inhibidores de pde10
CN103380130B (zh) 2011-02-18 2015-06-17 埃科特莱茵药品有限公司 用作为食欲素拮抗剂的新颖的吡唑和咪唑衍生物
CA2838645C (en) 2011-06-27 2020-03-10 Janssen Pharmaceutica Nv 1-aryl-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline derivatives
EP2731426A2 (en) 2011-07-15 2014-05-21 Basf Se Pesticidal methods using substituted 3-pyridyl thiazole compounds and derivatives for combating animal pests ii
BR112014019426A8 (pt) 2012-02-07 2017-07-11 Eolas Therapeutics Inc Prolinas/ piperidinas substituídas como antagonistas do receptor de orexina
US9440982B2 (en) 2012-02-07 2016-09-13 Eolas Therapeutics, Inc. Substituted prolines/piperidines as orexin receptor antagonists
ITMI20120322A1 (it) 2012-03-01 2013-09-02 Rottapharm Spa Composti di 4,4-difluoro piperidina
TWI510481B (zh) 2012-06-04 2015-12-01 Actelion Pharmaceuticals Ltd 苯并咪唑脯胺酸衍生物
US9669035B2 (en) 2012-06-26 2017-06-06 Janssen Pharmaceutica Nv Combinations comprising PDE 2 inhibitors such as 1-aryl-4-methyl-[1,2,4]triazolo-[4,3-A]]quinoxaline compounds and PDE 10 inhibitors for use in the treatment of neurological of metabolic disorders
WO2014009305A1 (en) 2012-07-09 2014-01-16 Janssen Pharmaceutica Nv Inhibitors of phosphodiesterase 10 enzyme
AU2013292529A1 (en) 2012-07-18 2015-02-12 Marvin J. Miller 5,5-heteroaromatic anti-infective compounds
MX2015004638A (es) 2012-10-10 2015-07-14 Actelion Pharmaceuticals Ltd Antagonistas de receptores de orexina los cuales son derivados de [orto bi-(hetero-) aril]-[2-meta bi-(hetero-) aril)-pirrolidin-1-il]-metanona.
JP2016510810A (ja) 2013-03-12 2016-04-11 アクテリオン ファーマシューティカルズ リミテッドActelion Pharmaceuticals Ltd オレキシン受容体アンタゴニストとしてのアゼチジンアミド誘導体
HUE035731T2 (hu) 2013-12-03 2018-05-28 Idorsia Pharmaceuticals Ltd (S)-(2-(6-klór-7-metil-1H-benzo[d]imidazol-2-il)-2-metilpirrolidin-1-il)(5-metoxi-2- (2H-l,2,3-triazol-2-il)fenil)metanon kristályos formája és alkalmazása orexin receptor antagonistaként
UA119151C2 (uk) 2013-12-03 2019-05-10 Ідорсія Фармасьютікалз Лтд КРИСТАЛІЧНА СОЛЬОВА ФОРМА (S)-(2-(6-ХЛОР-7-МЕТИЛ-1H-БЕНЗО[d]ІМІДАЗОЛ-2-ІЛ)-2-МЕТИЛПІРОЛІДИН-1-ІЛ)(5-МЕТОКСИ-2-(2H-1,2,3-ТРИАЗОЛ-2-ІЛ)ФЕНІЛ)МЕТАНОНУ ЯК АНТАГОНІСТ ОРЕКСИНОВОГО РЕЦЕПТОРА
LT3077391T (lt) 2013-12-04 2018-10-25 Idorsia Pharmaceuticals Ltd Benzimidazolo prolino darinių panaudojimas
AR101558A1 (es) 2014-08-13 2016-12-28 Eolas Therapeutics Inc Difluoropirrolidinas como moduladores del receptor de orexina
AU2017217931B2 (en) 2016-02-12 2020-10-22 Astrazeneca Ab Halo-substituted piperidines as orexin receptor modulators
WO2020007964A1 (en) 2018-07-05 2020-01-09 Idorsia Pharmaceuticals Ltd 2-(2-azabicyclo[3.1.0]hexan-1-yl)-1h-benzimidazole derivatives
WO2020099511A1 (en) 2018-11-14 2020-05-22 Idorsia Pharmaceuticals Ltd Benzimidazole-2-methyl-morpholine derivatives
MX2023001818A (es) 2020-08-13 2023-03-13 Boehringer Ingelheim Int Compuestos para usarse en tratamiento de deterioro cognitivo asociado con la esquizofrenia.
AU2021360172A1 (en) 2020-10-13 2023-03-30 Boehringer Ingelheim International Gmbh Process of reworking
JP7681113B2 (ja) * 2021-02-02 2025-05-21 メッドシャイン ディスカバリー インコーポレイテッド テトラヒドロピロロ環化合物及びその使用
WO2023218023A1 (en) 2022-05-13 2023-11-16 Idorsia Pharmaceuticals Ltd Thiazoloaryl-methyl substituted cyclic hydrazine-n-carboxamide derivatives
WO2025224168A1 (en) 2024-04-24 2025-10-30 Idorsia Pharmaceuticals Ltd Aryl sulfone and sulfanone derivatives as orexin receptor modulators

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0130335D0 (en) * 2001-12-19 2002-02-06 Smithkline Beecham Plc Compounds
JP2006504695A (ja) * 2002-09-18 2006-02-09 グラクソ グループ リミテッド オレキシン受容体アンタゴニストとしてのn−アロイル環状アミン
WO2008038251A2 (en) * 2006-09-29 2008-04-03 Actelion Pharmaceuticals Ltd 3-aza-bicyclo[3.1.0]hexane derivatives

Similar Documents

Publication Publication Date Title
JP2010534646A5 (en:Method)
ES2350460T3 (es) Derivados de 3-aza-biciclo[3.1.0]hexano.
RU2010138640A (ru) Производные 2-аза-бицикло [2.2.1] гептана
CN101568536B (zh) 作为食欲素受体拮抗剂的2-氮杂-双环[3.1.0]己烷衍生物
US8063099B2 (en) Trans-3-aza-bicyclo[3.1.0]hexane derivatives
EP2185512B1 (en) Trans-3-aza-bicyclo[3.1.0]hexane derivatives
JP2010534647A5 (en:Method)
JP5934403B2 (ja) 5,6−ジヒドロ−1h−ピリジン−2−オン化合物
JP2010536740A5 (en:Method)
JP2010514751A5 (en:Method)
JP2007519694A5 (en:Method)
JP2010504957A5 (en:Method)
KR20160142334A (ko) 시클로프로판아민 화합물 및 이의 용도
CA2729985A1 (en) Thiazolidine compounds as orexin receptor antagonists
CN101501039A (zh) 吡咯并[1,2-b]哒嗪酮化合物
CN108463461A (zh) 头孢烯化合物、其制备和用途
RU2010103322A (ru) Соединения 3-аза-бицикло[3.3.0]октана
IL307868A (en) Compounds for use in the treatment of hyperproliferative disorders
HK1136554B (en) 2-aza-bicyclo[3.1.0]hexane derivatives as orexin receptor antagonists
HK1201822B (en) Process for the preparation of 5,6-dihydro-1h-pyridin-2-one compounds